Discovery of new acetylcholinesterase inhibitors with small core structures through shape-based virtual screening

Bioorg Med Chem Lett. 2015 Sep 1;25(17):3442-6. doi: 10.1016/j.bmcl.2015.07.026. Epub 2015 Jul 17.

Abstract

Targeting acetylcholinesterase (AChE) using small molecule inhibitors is considered to be the most successful therapeutic strategy in the treatment of Alzheimer's disease (AD). Herein we present a shape-based virtual screening to identify new cores for the designing of AChE inhibitors. Ten active hits are identified and the most active hit, 5169-0032 and T5369186, showed comparable AChE inhibitory activity to tacrine. Prediction of physicochemical properties and ADME/T risk indicates their potential in druggability and safety. The two compounds provide new core and can serve as a promising fragment to design potent AChE inhibitors.

Keywords: AChEIs; Dual site inhibitor; Shape-based screening; Small molecule; Virtual screening.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminopyridines / chemistry*
  • Cholinesterase Inhibitors / chemistry*
  • Cytochrome P-450 CYP3A
  • Humans
  • Mass Screening
  • Models, Molecular

Substances

  • Aminopyridines
  • Cholinesterase Inhibitors
  • Cytochrome P-450 CYP3A